{"id":"NCT01183143","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization","officialTitle":"A Multicentre, Open-label, Non-comparative Phase IIIb Study to Evaluate the Acceptability of GONAL-f速 Prefilled Liquid Formulation Administered by Pen in an Outpatient Setting for Ovarian Stimulation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-05-11","primaryCompletion":"2006-03-02","completion":"2006-03-02","firstPosted":"2010-08-17","resultsPosted":"2018-04-06","lastUpdate":"2018-04-06"},"enrollment":215,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Infertility","Ovulation Induction","In-Vitro Fertilization"],"interventions":[{"type":"DRUG","name":"GONAL-f速","otherNames":["Follitropin alpha"]}],"arms":[{"label":"GONAL-f速","type":"EXPERIMENTAL"}],"summary":"This was a prospective, open-label, non-comparative, Phase IIIb trial to assess the convenience, safety and efficacy of the new Gonal-F fbm \\[recombinant follicle stimulating hormone (r-FSH)\\] liquid formulation, in common setting for ovulation induction (OI) and also in in-vitro fertilization (IVF).","primaryOutcome":{"measure":"Number of Subjects Who Self-administered the Investigational Medicinal Product (IMP)","timeFrame":"Up to 1 year","effectByArm":[{"arm":"GONAL-f速","deltaMin":159,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":215},"commonTop":["Injection site haemorrhage","Injection site erythema","Injection site pain","Ovarian hyperstimulation syndrome","Abortion spontaneous NOS"]}}